Compare NEXN & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEXN | SOPH |
|---|---|---|
| Founded | 2007 | 2011 |
| Country | Israel | Switzerland |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 367.2M | 342.6M |
| IPO Year | 2021 | 2021 |
| Metric | NEXN | SOPH |
|---|---|---|
| Price | $6.46 | $4.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | ★ $12.13 | $7.00 |
| AVG Volume (30 Days) | ★ 434.2K | 101.1K |
| Earning Date | 11-13-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 237.45 | N/A |
| EPS | ★ 0.62 | N/A |
| Revenue | ★ $376,353,000.00 | $73,297,000.00 |
| Revenue This Year | $5.43 | $16.60 |
| Revenue Next Year | N/A | $19.09 |
| P/E Ratio | $10.41 | ★ N/A |
| Revenue Growth | 7.80 | ★ 13.66 |
| 52 Week Low | $6.08 | $2.58 |
| 52 Week High | $12.60 | $5.30 |
| Indicator | NEXN | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 34.86 | 56.65 |
| Support Level | $6.35 | $4.54 |
| Resistance Level | $6.71 | $5.29 |
| Average True Range (ATR) | 0.26 | 0.32 |
| MACD | 0.06 | 0.04 |
| Stochastic Oscillator | 29.70 | 72.60 |
Nexxen International Ltd is a globalized and flexible advertising technology platform with deep expertise in data and advanced TV that helps empower advertisers, agencies, digital publishers and broadcasters to achieve desired outcomes, including increased efficiency and returns, across the media supply chain. It is a demand-side platform (DSP), supply-side platform (SSP), ad server, and data management platform (DMP) and also delivers a flexible and unified technology stack with and exclusive data at its core. Company operates in America, APAC, EMEA, regions, with majority revenue from America.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.